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Abstract 
Angiogenesis is a key factor of tumor progression. Considering, that the tumor vessels are heterogeneous and differ 
in morphology and clinical significance, the purpose of this research was to study of the morphological features of 
tumor vessels and their relationship with the clinical characteristics and morphological features of breast cancer (BC). 
In this pilot study the tumor samples received from 59 patients with T1–T2 stages of ductal invasive carcinomas were 
included. The sections were stained with hematoxylin and eosin and immunohistochemically using antibodies to 
CD34. The morphological features and the number of different types of tumor vessels were assessed microscopically 
and were compared with grade, lymph node metastasis, hormone receptors, HER2/neu status and with the presence 
of tumor emboli in vessels (lymphovascular invasion). We identified the following types of tumor vessels in BC: the 
normal microvessels, the dilated capillaries of peritumoral stroma, the atypical dilated capillaries and the “cavitary” 
structures (CS) type-1 and type-2 relating to the “cavitary” type of angiogenesis that was described by us earlier. The 
number of dilated capillaries correlated with CS type-1 (p = 0.003), CS type-2 (p = 0.002), atypical dilated capillar-
ies (p = 0.0008) and with lymphovascular invasion (p = 0.005); the presence of atypical dilated capillaries—with 
CS type-1 (p < 0.00001), CS type-2 (p = 0.00004), lymphovascular invasion (p = 0.0002) and with the tumor grade 
(p = 0.003); the number of CS type-1—with estrogen receptor (p = 0.002) and progesterone receptor (p = 0.002) 
status and with lymphovascular invasion (p = 0.004); the presence of CS type-2—with positive Her2/new status 
(p = 0.0002) and lymphovascular invasion (p = 0.01). The density of normal microvessels was not associated with 
other types of tumor vessels and with clinical characteristics of BC. These data indicate that varied types of tumor 
vessels are associated with different morphological characteristics of BC, such as hormone receptors and HER2/neu 
status, lymphovascular invasion. We believe that the atypical dilated capillaries are related to the “cavitary” type of 
angiogenesis. The strong correlations of lymphovascular invasion with CS type-1 and atypical dilated capillaries testify 
that the “cavitary” type of angiogenesis may play a significant role in the formation of tumor emboli in the vessels.
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Background
Breast cancer (BC) is the leading cause of cancer deaths 
among women. The prognosis of BC treatment results 
is a serious problem since a variety of clinical, morpho-
logical, molecular-biological and molecular-genetic fac-
tors influences the behavior of tumor cells and their 
response to the treatment. These factors include patient 
age, histological type and grade, tumor size, lymph node 
status, estrogen receptor (ER) and progesterone receptor 
(PR) status, and human epidermal growth factor recep-
tor 2 (HER-2) status (Fitzgibbons et al. 2000; Kalaja 2007; 
Lester et al. 2009). Although adjuvant treatment is being 
individualized according to these factors, not all patients 
show the same response to the treatment. In this respect 
the knowledge of the prognostic factors is important for 
predicting recurrence and metastasis and for choosing 
target therapies.
One of the most significant factors of tumor progres-
sion is angiogenesis (Folkman 1998). However, its role in 
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the progression of BC has been studied insufficiently and 
the received data are contradictory (Uzzan et  al. 2004). 
For example, several studies have indicated that a high 
microvessel density (MVD) in tumor is associated with 
more advanced stages and poor prognosis of BC (Pop-
iela et  al. 2008; Fernández-Guinea et  al. 2013; Li et  al. 
2013). At the same time, the other authors have found 
no association of MVD with clinical characteristics and 
long-term results of BC treatment (Fridman et al. 2000; 
Gasparini 2001; Mohammed et al. 2013). Even more, the 
individual researchers have shown that some blood ves-
sels presented within the tumor microenvironment can 
be associated with a favorable prognosis (Martinet et al. 
2013). We believe that the noted contradictions may be 
due to the fact that in most researches the study of the 
angiogenesis in BC has been carried out without the con-
siderations of the tumor vessels features. This approach is 
not quite justified since it is known that the blood vessels 
in tumors are heterogeneous and differ both in origin and 
morphology as well as in clinical significance (Fukumura 
et al. 2010; Birau et al. 2012; Nagy and Dvorak 2012; Mar-
tinet et al. 2013).
We have previously described a new way of angiogen-
esis, named by us the “cavitary” type of angiogenesis, 
and have showed its clinical significance on the example 
of gastric cancer (GC). This type of angiogenesis con-
sists in the formation of “cavitary” structures (CS) in the 
tumor stroma and adjacent gastric mucosa, being then 
lined by the endothelium and merged into the blood ves-
sels of the organ (Senchukova and Kiselevsky 2014). The 
obtained data have allowed us to propose the existence of 
two main mechanisms of CS formation. The first one is 
associated with the abruption of layers of epithelial cells 
from their underlying foundation and their desquama-
tion into the lumen of the “obliterated” tumor glands, the 
second—with the formation of CS directly in the tumor 
stroma or adjacent tissue. In our study the presence of 
multiple CS type-1 was associated with the T3-4 and N2 
stages as well as with the decrease of long-term results of 
GC treatment. The presence of CS type-2 was only asso-
ciated with the diffuse type of GC.
Considering the difference of the contribution of vari-
ous types of vessels in the tumor progression, the pur-
pose of this research was to study the morphological 
features of tumor vessels and their relationship with the 
clinical and morphological features and with the tumor 
receptor status of BC.
Methods
Patients
Fifty nine patients with invasive ductal BC who had 
undergone surgery between May 2011 and April 2013 at 
the Orenburg Regional Clinical Oncology Center, were 
included in this pilot study. The study was performed in 
accordance with the Helsinki Declaration, internationally 
recognized guidelines, and the privacy of patients was 
protected by decoding of data according to the privacy 
regulations of the Orenburg Regional Clinical Onco-
logic Center (Russia, Orenburg). Written informed con-
sent was obtained from the patient and the protocol was 
approved by the Institutional Review Board of the Oren-
burg State Medical University (Russia, Orenburg).
Clinical and pathological data including age, grade, 
tumour size, lymph node status were retrieved from the 
routine reports. Information regarding estrogen (ER), 
progesterone (PR) receptor status and HER-2 status was 
retrieved from the pathology reports. Tumor size and 
nodal status were categorized according to the TNM 
classification of malignant tumors (the 7th edition), and 
histological grade was evaluated using the Nottingham 
modification of the Bloom and Richardson histological 
grading criteria (Robbins et al. 1995). These data are sum-
marized in the Table  1. The average age of the patients 
was 58.1 ± 10.1 years (from 35 to 75 years, the median—
was 57 years). All patients were treated with either modi-
fied radical mastectomy (n  =  45) or breast-conserving 
therapy (n = 14), but all with adequate lymph node dis-
section (at least 10–12 nodes were examined). None of 
the patients recruited in this study were undergone pre-
operative chemotherapy or radiotherapy.
Pathology
The sections (4  mm) were cut from the formalin-fixed 
paraffin embedded blocks. One section was stained with 
Mayer’s hematoxylin and eosin (H&E). Histological slides 
were studied by light microscopy (Optika B-350 micro-
scope, connected to a ScopeTek DCM500 camera, Italy). 
The number of dilated capillaries (DCs) and CS type-2 
were assessed by visual analog way using a 200× magni-
fication (none, single—no more than two in the field of 
view, and multiple—more than two in the field of view). 
The presence or absence of local lymphoid infiltrates 
(LI) and loose fine-fibered connective tissue (LFFCT) in 
peritumoral stroma was estimated in the same way. All 
sections were carefully and completely scanned by two of 
the authors (MS and NP) without knowledge of the clini-
cal and pathological data.
Immunohistochemistry
Forty five sections were stained with antibody to CD 
34. The sections for immunohistochemistry (IGH) were 
dewaxed and rehydrated by sequential immersion in 
xylene and graded into ethanol and water. For antigen 
retrieval the sections were boiling for 10  min in cit-
rate buffer (pH 6) and endogenous peroxidase activity 
was blocked with 30  mL/L hydrogen peroxide solution. 
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Adjacent slides were incubated at a room temperature 
with the anti-CD34 (QB–END/10, Novocastra Labora-
tories Ltd) monoclonal antibodies in diluted at 1:50. The 
time of antibodies incubation was according to the man-
ufacturer protocol. The visualization system included 
DAB (UltraVision LP Detection System HRP Polymer 
and DAB Plus Chromogen) and hematoxylin counter-
staining. For negative control sections primary antibody 
was replaced with phosphate-buffered saline and pro-
cessed in the same manner.
The slides were briefly scanned at low power, and intra- 
and peritumoral areas with the highest density of CД34-
positive vessels were identified. Intratumoral vessels were 
defined as those located within the tumor mass. Peritu-
moral vessels were those located outside of the tumor 
mass but within 2 mm from the tumor edge. The num-
ber of atypical dilated capillaries (ADCs) and CS type-1 
were calculated by visual analog way using a 200× mag-
nification (none, single—no more than two in the field of 
view, and multiple—more than two in the field of view). 
Microvessels density (MVD) was assessed in accordance 
with the international consensus on the methodology 
and criteria for quantitative evaluation of angiogenesis in 
human solid tumors (Vermeulen et  al. 2002). MVD was 
determined by counting the number of CД34-positive nor-
mal microvessels (MVs) in five high-power (200×) fields in 
the selected ‘hot-spot’ areas, and the mean values of vessel 
counts were obtained. A single, countable microvessel was 
defined as any brown-stained endothelial cell (or cluster) 
clearly separated from the adjacent microvessels.
Statistics
Statistical analysis was performed using the Statistica 
6.0 software. The MVD were expressed as mean ±  SD. 
Kruskal–Wallis and Mann–Whitney U nonparametric 
tests were used to compare the value of MVD. The cor-
relations between different data were evaluated using 
nonparametric Spearman’s rank correlation or gamma 
correlation. Chi square tests were carried out to analyze 
the difference of distribution among the categorized data. 
A value of P < 0.05 was considered statistically significant.
Results
The study showed that in BC the tumor vessels are het-
erogeneous in morphology and clinical significance. We 
identified the following types of tumor vessels:
The normal microvessels (MVs) of peritumoral 
and intratumoral stroma
These vessels were presented by the capillaries with 
diameter of 5–40  μm. The endothelium lining of such 
vessels had a flat hyperchromic nucleus. Cytoplasm of 
endothelial cells uniformly and intensively was being 
colored by CD34 marker and had clear contours (Fig. 1).
The dilated capillaries (DCs) of peritumoral stroma
The large vessels were often of rounded or oval shape 
with a diameter of more than 40 microns (average diame-
ter 87.8 ± 64.4 microns). A distinguishing feature of such 
vessels was that the cells with large, pale nuclei with fine-
netted chromatin structure took part in their formation 
(Fig. 2). The cytoplasm of the lining cells was being evenly 
stained by CD34 and had the clear contours (Fig. 3). The 
presence of the described vessels was often associated 
with a characteristic structure of peritumoral stroma pre-
sented by a LFFCT being rich by fibroblasts (Fig. 4).
The atypical dilated capillaries (ADCs)
The ADCs were presented the vessels of irregular shape 
with a diameter of 40 microns or more and with the 
Table 1 Clinicopathologic characteristics of  breast carci-
noma cases
Clinicopathologic variables Number of cases (n) Percent (%)
Age
 <50 11 18.6
 >50 48 81.4
Tumor status (T)
 pT1 21 35.6
 pT2 38 64.4
Nodal status (N)
 pN0 30 50.8
 pN1 15 25.4
 pN2 1 1.7
 pN3 13 22.1
Number of lymph nodes
 0 30 50.8
 1–3 20 33.9
 4–6 6 10.2
 >6 3 5.1
Tumour grade
 G1 7 11.9
 G2 42 71.2
 G3 10 16.9
ER status
 Negative 29 49.1
 Positive 30 50.9
PR status
 Negative 38 64.4
 Positive 21 35.6
HER2/neu status
 Negative 48 81.4
 Positive 11 18.6
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marked atypia of the lining endothelial cells. These ves-
sels were observed mainly in the intratumoral stroma. A 
characteristic feature of the described vessels was a cha-
otic arrangement of the endothelial cells. The cytoplasm 
of the lining cells was unevenly stained by CD34 and had 
an uneven surface with a number of protuberances, so 
that the contours of the vessels seemed to be indistinct 
(Figs. 5, 6). In the lumen of such vessels the tumor emboli 
were often being defined (Figs. 7, 8).
The “cavitary” structures type‑1 (CS type‑1)
As it had been previously described, the CS with partial 
endothelial lining were the main feature of the “cavitary” 
angiogenesis type-1 (Senchukova et al. 2015). In BC the 
CS without endothelial lining (Fig. 9), the CS with partial 
Fig. 1 The normal microvessels of intratumoral stroma, immunoper-
oxidase staining with the anti-CD34 monoclonal antibody, ×400
Fig. 2 The dilated capillary in peritumoral stroma (arrow), H&E stain, 
×400
Fig. 3 The dilated capillary in peritumoral stroma (arrow), immunop-
eroxidase staining with the anti-CD34 monoclonal antibody, ×400
Fig. 4 A loose fine-fibered connective tissue with fibroblasts (arrows) 
in peritumoral stroma, H&E stain, ×400
Fig. 5 The atypical dilated capillary  (arrow) with chaotic arrange-
ment of the endothelial cells.  Their cytoplasm has an uneven surface 
with a number of protuberances, immunoperoxidase staining with 
the anti-CD34 monoclonal antibody, ×400
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endothelial lining (Fig. 10) and the CS with full endothe-
lial lining (Figs. 11, 12) were observed in intratumoral and 
more rarely in peritumoral stroma. As in ADC the cyto-
plasm of the endothelial cells in CS type-1 with partial 
endothelial lining was also unevenly stained by CD34 and 
had an uneven surface with a number of protuberances.   
The “cavitary” structures type‑2 (CS type‑2)
We observed CS type-2 only in the above-described 
LFFCT of peritumoral stroma. In these cases the LFFCT 
had a distinctive cellular structure (Fig.  13). The CS 
type-2 had a correct form, often oval. Some CS type-2 
had the endothelial lining the cells of which were very 
poorly expressed CD34 (Fig. 14).
The association of different types of tumor vessels with the 
clinical and morphological characteristics of breast cancer
The normal MVs of peritumoral and intratumoral stroma
MVD in peritumoral and intratumoral stroma was 
9.8  ±  3.9 and 9.8  ±  3.2 on area unit, respectively. The 
Spearman rank correlation analysis (ρ) showed that the 
MVD in peritumoral stroma correlated with the pres-
ence of lymph node metastases (σ = −0.310, t = −2.14, 
p =  0.04). The MVD in peritumoral stroma was higher 
in the absence of metastasis than in their presence 
(9.34  ±  3.00 and 10.22  ±  4.84, p  =  0.04, respectively, 
Mann–Whitney U Test). The correlations of MVD in 
intratumoral stroma with clinical characteristics of BC 
were not identified.
Fig. 6 The atypical dilated capillary (arrow). The vessel has irregular 
shape and chaotic arrangement of the endothelial cells, immunoper-
oxidase staining with the anti-CD34 monoclonal antibody, ×400
Fig. 7 The atypical dilated capillary (arrow) with tumor emboli in the  
lumen, immunoperoxidase staining with the anti-CD34 monoclonal 
antibody, ×400
Fig. 8 The atypical dilated capillary (arrow) located in the intra-
tumoral stroma. Several tumor cells are observed in the lumen of 
vessel, immunoperoxidase staining with the anti-CD34 monoclonal 
antibody, ×400
Fig. 9 The “cavitary” structures type-1 (arrows) without endothelial 
lining, immunoperoxidase staining with the anti-CD34 monoclonal 
antibody, ×400
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The DCs of peritumoral stroma
The single DCs were detected in 26 patients (44.1 %), the 
multiple - in 26 patients (44.1  %), the DCs were absent 
in 7 (11.8  %). The gamma correlation coefficient test 
(gamma) showed that the number of DCs correlated with 
the presence of LI (γ = 0.489, Z = 3.66, p = 0.0002) and 
LFFCT (γ = 0.563, Z = 3.54, p = 0.0004) in the peritu-
moral stroma, the presence of CS type-1 with partial 
endothelial lining (γ =  0.574, Z =  2.99, p =  0.003), the 
presence of CS type-2 (γ = 0.522, Z = 3.14, p = 0.002), 
the presence of ADCs (γ = 0.533, Z = 3.35, p = 0.0008) 
and with the presence of tumor emboli in vessels 
(γ =  0.520, Z =  2.83, p =  0.005). It was not associated 
with clinical characteristics of BC.
The multiple DCs were more often observed in the 
presence of LI (in 29.1 and 69.6 % cases in the presence 
and absence of LI, respectively, χ2  =  10.22, p  =  0.04) 
and LFFCT (in 53.8 and 25 % cases in the presence and 
absence of LFFCT, respectively, χ2  =  7.14, p  =  0.03, 
respectively) in peritumoral stroma.
In the presence of multiple DCs, the CS type-1 with 
partial endothelial lining, CS type-2, ADCs and tumor 
emboli in vessels were more often revealed (Table 2).
The ADCs
The presence of ADCs was associated with the grade 
of BC (γ  =  0.525, Z  =  2.40, p  =  0.003), estrogen (ER) 
and progesterone (PR) receptor status (γ  =  −0.325, 
Z  =  −2.01, p  =  0.045), the presence of CS type-1 
with partial endothelial lining (γ  =  0.753, Z  =  5.27, 
p  <  0.00001), the presence of CS type-2 (γ  =  0.717, 
Fig. 10 The “cavitary” structure type-1 (arrow) with partial endothelial 
lining, immunoperoxidase staining with the anti-CD34 monoclonal 
antibody, ×400
Fig. 11 The “cavitary” structure type-1 (arrow) with full endothelial 
lining, immunoperoxidase staining with the anti-CD34 monoclonal 
antibody, ×400
Fig. 12 Several “cavitary” structures type-1 (arrows) with full endothe-
lial lining, immunoperoxidase staining with the anti-CD34 monoclo-
nal antibody, ×400
Fig. 13 A characteristic cellular structure of loose fine-fibered con-
nective tissue in peritumoral stroma, H&E stain, ×400
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Z = 4.13, p = 0.00004) and with the presence of tumor 
emboli in vessels (γ = 0.647, Z = 3.81, p = 0.0002).
The multiple ADCs were significantly more often in 
grade G2–G2 (in 0, 43.8 and 50  % cases in G1, G2 and 
G3, respectively, χ2  =  11.28, p  =  0.03), in negative RE 
status (in 60.0 and 15.0 % cases, in negative and positive 
RE status, respectively, χ2 = 9.69, p = 0.008), in negative 
RP status (in 47.1 % и 18.2 % cases, in negative and posi-
tive RP status, respectively, χ2 = 2.98, p = 0.22).
In the presence of multiple ADCs the CS type-1 with 
partial endothelial lining, CS type-2 and tumor emboli in 
vessels were revealed significantly more often (Table 3).
The “cavitary” structure type‑1 (CS type‑1)
The number of CS type-1 with partial endothelial lin-
ing also correlated with ER (γ  =  −0.622, Z  =  −3.08, 
p  =  0.002) and PR status (γ  =  −0.645, Z  =  −3.12, 
p = 0.002) and with a presence of tumor emboli in vessels 
(γ = 0.515, Z = 2.92, p = 0.004).
The CS type-1 were more often observed in negative 
RE status (in 84.0 % and 55.0 % cases in negative and pos-
itive RE status, respectively, χ2 = 4.55, p = 0.03) and in 
negative RP status (in 79.4 and 45.5 % cases, in negative 
and positive RP status, respectively, χ2 = 4.66, p = 0.03).
In the cases of multiple CS type-1 the tumor emboli in 
vessels were more often revealed (in 46.2, 55.6 and 85.7 % 
cases, in the absence of CS type-1, single and multiple 
ones, respectively, χ2 = 5.05, p = 0.08).
The “cavitary” structures type‑2 (CS type‑2)
The presence of CS type-2 were associated with the pres-
ence of LFFCT in the peritumoral stroma (γ  =  0.983, 
Z = 11.19, p < 0.00001), with the positive Her2/new sta-
tus (γ = 0.680, Z = 3.66, p = 0.0002) and with the pres-
ence of tumor emboli in vessels (γ  =  0.441, Z  =  2.48, 
p = 0.01).
The CS type-2 were more often observed in the pres-
ence of LFFCT in peritumoral stroma (in 97.4 and 0  % 
cases in the presence and absence of LFFCT, respectively, 
χ2 =  54.75, p  <  0.00001) and in positive Her2/new sta-
tus (in 100.0 and 56.3 % cases in the positive and nega-
tive Her2/new status, respectively, χ2 = 9.69, p = 0.008). 
In the presence of CS type-2 the tumor emboli in vessels 
were more often revealed (in 43.7, 69.2 and 75.0 % cases 
Fig. 14 The “cavitary” structure type-2 with endothelial lining having 
a very weak expression of CD34 (6b), immunoperoxidase staining 
with the anti-CD34 monoclonal antibody, ×400
Table 2 The presence of  atypical dilated capillaries, CS type-1 with  partial endothelial lining, CS type-2 and  tumor 
emboli in vessels depending on the number of dilated capillaries in peritumoral stroma
The number of dilated capillaries p value 
No Single Multiple
n % n % n %
Atypical dilated capillaries
 No 2 40.0 7 33.3 1 5.3  0.13
 Single 2 40.0 8 38.1 7 36.8
 Multiple 1 20.0 6 28.6 11 57.9
CS type-1
 Absent 2 40.0 9 42.9 2 10.5  0.07
 Present 3 60.0 12 57.1 17 89.5
CS type-2
 Absent 6 85.7 20 66.9 11 42.3  0.02
 Present 1 14.3 6 23.1 15 57.7
Tumor emboli
 Absent 3 60.0 10 47.6 4 21.0  0.12
 Present 2 40.0 11 52.4 15 78.9
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in the absence of CS type-2, single and multiple ones, 
respectively, χ2 = 3.71, p = 0.16).
Discussion
A large amount of studies testified that the vessels in the 
tumor are heterogeneous and differ in origin, morphol-
ogy, clinical significance and sensitivity to anti-angio-
genic therapy (Baluk et  al. 2005; Luukkaa et  al. 2007; 
Mucci et al. 2009; Taverna 2009; Birau et al. 2012; Fuku-
mura et al. 2010; Nagy and Dvorak 2012; Mikalsen et al. 
2013). In this study we decided to investigate the mor-
phological features of tumor vessels in BC. The obtained 
data allowed us to identify the several types of tumor ves-
sels differing both in morphology and clinical relevance: 
the normal MVs, DCs of peritumoral stroma, ADCs and 
the CS type-1 and type-2 relating to “cavitary” type of 
angiogenesis (Senchukova and Kiselevsky 2014).
The normal MVs were presented the capillaries of 5–40 
microns in diameter. Their endothelial lining was inten-
sively and uniformly being stained by CD34. MVD was 
absolutely identical in peri- and intratumoral stroma. 
However, MVD in peritumoral stroma was slightly higher 
in the absence of metastases in lymph nodes than in the 
presence of them (p = 0.04), that was not entirely clear. 
We did not identify the relation of MVD with other clini-
cal characteristics of BC. These results contradict the 
data of other authors that found an association of MVD 
with clinical characteristics and prognosis of BC (Li et al. 
2006; Popiela et  al. 2008; Fernández-Guinea et  al. 2013; 
Li et al. 2013). We believe that the reason for these con-
tradictions are due to the fact that in contrast to the 
above-mentioned authors in calculating of MVD we 
took into account only the normal microvessels, while 
the prognosis was associated with other types of tumor 
vessels.
The DCs were revealed in the peritumoral stroma in 
88.2 % of cases. A distinguishing feature of such vessels 
was that the cells with large, pale nuclei with fine-netted 
chromatin structure took part in their formation. The 
cytoplasm of lining cells was uniformly being stained by 
marker and had clear contours. The localization of ves-
sels in peritumoral stroma and the lack of red blood cells 
in their lumen testified in favor of the fact that these ves-
sels were lymphatic ones. But for a more precise determi-
nation of their origin the additional research with using 
the special markers such as D2-40 is needed.
The presence of these vessels was not associated with 
clinical characteristics of BC but their number was posi-
tively correlated with the number of ADCs, CS type-1 and 
CS type-2 as well as with the presence of LFFCT and LI 
in the peritumoral stroma. We believe that this fact is the 
indicative of the existence of common mechanisms in the 
formation of described vessels. And these mechanisms 
have its origin in the close relationship of the processes of 
stroma formation, angiogenesis, lymphangiogenesis and 
inflammation (Ebelt et al. 2013; Costa et al. 2014; Sharon 
et al. 2015). Furthermore, the features of the described ves-
sels allow us to suggest that angioblasts should participate 
in their formation. Their involvement in tumor angiogene-
sis has been described by many researchers (Sussman et al. 
2003; Richter-Ehrenstein et al. 2007; Naik et al. 2008).
It should be noted that one of the most important 
prognostic criteria in BC comparable to the status of the 
lymph nodes is lymphovascular invasion (LVI). LVI is the 
presence of tumor cells in blood and/or lymphatic ves-
sels. A large number of studies testifies that this indicator 
Table 3 The presence of  CS type-1 with  partial endothelial lining, CS type-2 and  tumor emboli in  vessels depending 
on the number of atypical dilated capillaries
The number of atypical dilated capillaries p value
No Single Multiple
n % n % n %
CS type-1
 No 7 70.0 4 23.5 2 11.1 0.0004
 Single 3 30.0 10 58.8 5 27.8
 Multiple 0 0 3 17.7 11 61.1
CS type-2
 No 3 30.0 8 47.1 5 27.8 0.14
 Single 5 50.0 5 29.4 3 16.7
 Multiple 2 20.0 4 23.5 10 55.6
Tumor emboli
 Absent 7 70.0 7 41.2 3 16.7 0.02
 Present 3 30.0 10 58.8 15 83.3
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is associated with the size of the tumor with the presence 
of lymph node metastases and prognosis of BC (Kato 
et al. 2003; Lee et al. 2006; Arnaout-Alkarain et al. 2007; 
Gudlaugsson et  al. 2011; Rakha et  al. 2012; Moham-
med et al. 2013). At the St. Gallen meeting in 2005, LVI 
was recognised as a prognostic factor for node-negative 
patients (Goldhirsch et  al. 2005). However, we empha-
size that LVI is not an independent prognostic factor of 
BC. LVI is also associated with other prognostic factors 
including tumor size, grade and loco-regional lymph 
node involvement, expression of VEGF-C (Lee et  al. 
2006; Li et al. 2006; Freedman et al. 2012). In some stud-
ies the relationship of LVI with the RE status was noted, 
however, the connection of LVI with the HER2 status was 
not marked (Marinho et al. 2008; Ragage et al. 2010; Song 
et al. 2011; Lee et al. 2011; Mohammed et al. 2013).
Despite the fact that the LVI has long been used as an 
important prognostic factor, the mechanisms of the tumor 
emboli formation in the vessels are still unclear. Using the 
notion of “metastatic cascade” (Engers and Gabbert 2000; 
Weigelt et al. 2005) it is extremely difficult to explain how 
the large portions of the tumor tissue are placed into 
the lumen of vessels. However, this phenomenon is well 
explained by the hypothesis of “cavitary” type of angio-
genesis, proposed by us earlier (Senchukova and Kise-
levsky 2014; Senchukova et  al. 2015). According to this 
hypothesis, the formation of blood vessels can occur due 
to the formation of the CS in tumor stroma, being then 
lined by the endothelium and merged into the blood ves-
sels of the organ. We have noted two main types of the CS 
formation: formation of CS at the expense of abruption 
of layers of epithelial cells from their underlying founda-
tion (CS type-1) and the formation of CS directly in the 
tumors stroma at the expense of active processes of for-
mation and lysis of its elements (CS type-2). We believed 
that the formation of the CS type-1 was directly associ-
ated with the phenomenon of stroma retraction that had 
been described previously (Acs et al. 2007, 2012).
The analysis of our data showed that in BC the presence 
of LVI was closely associated with the CS type-1 with the 
partial endothelial lining (p = 0.004) and with the ADCs 
(p  =  0.0002). We believe that most probably the ADCs 
have direct relation to “cavitary” angiogenesis type-1 as 
these two factors were closely correlated with each other 
(p < 0.00001). The ADCs and CS type-1 was most often 
observed in the ER and PR negative tumors. At the same 
time, their presence was not associated with Her 2 new 
status. It was difficult to judge the origin of ADCs because 
in our study we used the marker of CD34 staining both 
the lymph and blood vessels. Considering that the eryth-
rocytes were often defined in the lumen of ADCs and 
taking into account the data of different authors showing 
that the intratumoral lymphatic vessels were extremely 
rare (Schoppmann et al. 2004; Kato et al. 2005; Gudlaugs-
son et  al. 2011), we think that ADCs is likely to have a 
bearing on the blood vessels. More precisely the affilia-
tions of these vessels may be determined using the spe-
cific methods of lymphatic vessels staining, e.g. CD2-40. 
The research of this kind seems to be important since 
the clinical evidence testifies that the hematogenous and 
lymphogenous path of metastasis are independent factors 
associated with the progression of BC.
As for the CS type-2, of particular interest is the rela-
tionship of these vessels with the LFFCT (p  <  0.00001) 
and Her2/new status (p =  0.0002). These data can have 
both the theoretical and prognostic value since they show 
that the Her2/new status is closely linked with the stroma 
formation and with and angiogenesis as well. Also it was 
noted a close link of Her2/new status with the presence 
of tumor emboli in the vessels (P = 0.004) but its connec-
tion with CS type-1 was not observed.
Thus, these data indicate that in BC the tumor vessels 
are heterogeneous in morphology and clinical signifi-
cance. The most significant structures in terms of prog-
nosis are CS type-1 and type-2 and ADCs. The CS type-1 
and ADCs are associated with the presence of tumor 
emboli in the vessels (LVI) and with the negative ER and 
PR status, and the CS type-2—with positive Her2/new 
status and with the presence of LFFCT. The obtained data 
may be of theoretical and practical interest. We believe 
that further studies are required for the understanding of 
angiogenesis mechanisms in breast cancer.
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